Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 37,591Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10CELATOR PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 8022279

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3147

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-09-14

blank

02

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 7850990

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3147

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-01-23

blank

03

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 10835492

Drug Substance Claim :

Drug Product Claim :

Application Number : 209401

Patent Use Code : U-3150

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-15

blank

04

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 10028912

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3150

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-15

blank

05

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 10028912

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3149

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-15

blank

06

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 10166184

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3149

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-10-15

blank

07

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 8431806

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code : U-3147

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-22

blank

08

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 8092828

Drug Substance Claim :

Drug Product Claim :

Application Number : 209401

Patent Use Code : U-3147

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-04-01

blank

09

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 8518437

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-07

blank

10

arrow
Pharma Manufacturing 2024
Not Confirmed
arrow
Pharma Manufacturing 2024
Not Confirmed

CYTARABINE; DAUNORUBICIN

US Patent Number : 9271931

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209401

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-01-23

blank